CGP-53353
CGP-53353 (DAPH-7) is an potent PKC inhibitor with IC50s of 0.41 μM and 3.8 μM for PKCβII and PKCβI, respectively. CGP-53353 can inhibit glucose-induced cell proliferation and DNA synthesis in AoSMC and A10 cells. CGP-53353 can be used for researching atherosclerosis of diabetic patients[1].
Product Specifications
CAS Number
145915-60-2
Product Name Alternative
DAPH-7
UNSPSC
12352005
Target
DNA/RNA Synthesis; PKC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; TGF-beta/Smad
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cgp-53353.html
Concentration
10mM
Purity
98.87
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C1NC(C2=C1C=C(NC3=CC=C(F)C=C3)C(NC4=CC=C(F)C=C4)=C2)=O
Molecular Formula
C20H13F2N3O2
Molecular Weight
365.33
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKCβ
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD201, ID (PROCR, EPCR, Endothelial protein C receptor, Activated protein C receptor, Endothelial cell protein C receptor, CD201) (MaxLight 550)
CD201, ID (PROCR, EPCR, Endothelial protein C receptor, Activated protein C receptor, Endothelial cell protein C receptor, CD201) (MaxLight 550)
Lentiviral mouse Avil shRNA (UAS) - Lentiviral mouse Avil shRNA (UAS, RFP) plasmid